PMID: 8970768Oct 1, 1996Paper

Novel nonpeptide antiplatelet glycoprotein IIb/IIIa receptor antagonist, DMP754: receptor binding affinity and specificity

Coronary Artery Disease
S A MousaThomas M Reilly

Abstract

To define the antiplatelet efficacy and specificity of the glycoprotein IIb/IIIa complex (GPIIb/IIIa) antagonist prodrug DMP754 and its free acid form, XV459. DMP754 has an IC50 > 1 mumol/l, and, upon its conversion with esterases to its free acid form, demonstrated high potency (IC50 20-45 nmol/l) in inhibiting human platelet aggregation induced by 10 mumol/l adenosine diphosphate, 20 micrograms/ml collagen, 1 mmol/l epinephrine, 10 mumol/l platelet activating factor or 0.5 IU/ml thrombin. The in-vitro rate of hydrolysis of DMP754 or XV459 is much faster with human or canine liver esterases (t 1/2 = 2.4-23 min) than with plasma esterases (t 1/2 = 5.5-7.6 h). Platelet GpIIb/IIIa integrin binding affinity and specificity for XV459 were determined using cell binding/adhesion assays. The range of IC50 values of XV459 in inhibiting platelet aggregation in platelet-rich plasma obtained from 12 subjects was 0.035-0.069 mumol/l with a mean IC50 of 0.050 +/- 0.003 mumol/l. Additionally, XV459 inhibited platelets obtained from mongrel dogs, baboons, sheep, guinea pigs, and mice with IC50 in the range 0.024-0.06 mumol/l, and IC50 in the range 0.16-5.8 mumol/l in pigs, rabbits, and rats. XV459 inhibited [125I]-fibrinogen binding to activa...Continue Reading

Citations

Jul 5, 2005·Expert Opinion on Investigational Drugs·S A Mousa
Jan 18, 2005·Journal of Cardiovascular Pharmacology·Shaker A Mousa, Seema Mohamed
Feb 24, 2001·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·M K Orcullo SantillanJ Fareed
Mar 30, 2005·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Shaker A MousaGiora Z Feuerstein
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Joseph MurphyStephen L Kopecky
Apr 28, 1999·Journal of Cardiovascular Pharmacology·S A MousaT M Reilly
Jul 21, 1998·Thrombosis Research·R R Hantgan, S A Mousa
Apr 10, 1999·Journal of Medicinal Chemistry·R E OlsonR R Wexler
Jan 14, 2000·Journal of Medicinal Chemistry·D G BattP K Jadhav
Dec 2, 1999·Journal of Medicinal Chemistry·M J FisherS L Um
Jun 20, 1997·Journal of Medicinal Chemistry·C B XueR E Olson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.